David Holland - 29 Oct 2021 Form 4 Insider Report for ALIMERA SCIENCES INC

Role
Chief Marketing Officer & SVP
Signature
/s/ David Holland
Issuer symbol
N/A
Transactions as of
29 Oct 2021
Net transactions value
+$1,878
Form type
4
Filing time
02 Nov 2021, 16:58:27 UTC
Next filing
04 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALIM Common Stock Award $1,878 +500 +2% $3.76 26,130 29 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).